https://www.cancer.net/research-and-advocacy/cancer-awareness-dates https://lnkd.in/exYNn59 Visit us online @ guardanthealthamea.com to find […] CME Accredited. Stacy was appointed Chief Commercial Officer effective September 1, 2018. Previously he was head of Computational Biology at Rosetta Genomics, where he led development of molecular diagnostic tests for cancer. Prior to joining Inivata Charlie led international technology operations for D-Wise, a consulting firm focusing on healthcare and life sciences. Jacqui brings an extensive background of working internationally as an HR Director, People Developer, and consultant within various organizations at a senior level. Open the Site. We’re ready to take you in the right direction. While at Talecris, Tim managed the Initial Public Offering (IPO) at a $3.28 billion valuation and has managed merger and acquisition transactions. Jeff received a Bachelor of Science Degree in Finance from Seton Hall University and a Master of Business Administration in Marketing from Temple University. Stacy earned her MBA in Finance from Rutgers University and her BBA in Marketing from the University of Georgia. CAMBRIDGE, Mass. Citing the COVID-19 pandemic and the impact and stress it is putting on the international health care, economic and transportation systems, the International Association for the Study of Lung Cancer (IASLC) today announced it is postponing the 2020 World Conference on Lung Cancer (WCLC 2020) from August 9-12, 2020 to January 26-29, 2021. Charlene Knape is SVP, Strategic Programs at Inivata and brings more than 25 years of experience and leadership in key areas including Clinical Affairs, Regulatory Affairs, Quality, Program Management and the Clinical Laboratory. Robert Osborne is SVP, Technology and Assay Development at Inivata. Alan brings to the role over 25 years of genetics and molecular diagnostics experience. From 1991 to 2018, the cancer death rate has fallen 31%. For his contributions, he received numerous awards including the CRUK Future Leaders in Cancer Research prize, the Foulkes Foundation Medal, and the Pezcoller Foundation – EACR Cancer Research Award, and was elected as a fellow of the British Academy of Medical Sciences. title title Type Type. He subsequently worked for Fusion IP plc, a specialist investor in university spin-out companies, before joining IP Group in 2014. Dr Wrighton-Smith is the Chief Executive Officer and Founder of Oxford Immunotec Glob al PLC, a high-growth global diagnostics company focussing on monitoring immune-regulated conditions. Eleven AstraZeneca medicines and potential new medicines from the pipeline feature in 39 abstracts showcasing the Company’s leadership across different types and stages of lung cancer… Predictive tests to show who is immune and who will develop disease from novel infections. World Lung Day 2020 calls for research to prevent, detect and treat respiratory infections, particularly COVID-19 and TB. Mr. VanOort currently serves as a member of the Board of Directors of several privately-held companies, and is a principal owner of a privately-held retail hardware store chain. Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients. ET / Saturday, January 30, at 7:00 a.m. JST. Mr. VanOort is a graduate of Bentley University. Jeff has been recognised for his work, receiving the Joseph F. Buckley Memorial Award from the American Cancer Society for commitment to cancer control and involvement in the oncology pharmaceutical field. Date of preparation: January 2021 This report has been developed by the World Economic Forum and the Lung Ambition Alliance, in collaboration with AstraZeneca. Before joining Inivata in April 2019, Robert was a Principal Staff Scientist at the Wellcome Trust Sanger Institute where he developed new approaches to quantitate somatic variants in polyclonal tissues. (2021, January 11). The IASLC World Conference on Lung Cancer (IASLC WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. She is a visiting lecturer on the MSc Pharmaceutical Medicine curriculum at Trinity College in Dublin, Ireland. He is also a non-executive director of Wheatsheaf investments and the InnovateUK Medicines Discovery Catapult. Journal of Thoracic Oncology & JTO Clinical and Research Reports. His work combines new molecular and genomics approaches to develop new diagnostic tools and applications. He was then part of the founding management team of an in vitro diagnostics company before moving into venture capital investment with Inventages, a life science focused VC fund. Conference President. In fact, the first two known patients in the United States who received double-lung transplants due to COVID-19 were Mayra Ramirez, 28, of Chicago, on … CAP No: 9469405, Privacy Policy Alan Schafer is Chief Technology Officer at Inivata. He brings extensive commercial and drug development experience in oncology and other therapeutic areas. Stacy brings over 25 years of US healthcare commercial experience to Inivata. Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. WCLC 2020 Virtual Presidential Symposium on August 8, 2020. The death rate from cancer in the United States has continued to decline. More than 7,000 delegates come from more than 100 countries … IMPORTANT NOTICE: This event has been cancelled in person and becomes virtual. She was most recently consulting for various companies, where her primary focus was to identify and develop a sustainable supply of leadership and talent from within these organizations. Craig has a first-class honours degree in Pharmacy from Cardiff University and a PhD from the School of Pharmacy, University of Nottingham. Why COVID-19 pneumonia lasts longer, causes more damage than typical pneumonia: COVID-19 pneumonia spreads like multiple wildfires, leaving destroyed lung … Friday, February 5, 2021 – Sunday, February 7, 2021. Peter has led Oxford Immunotec from the foundation stages, through product development to regulatory approval in over 50 countries, and subsequent worldwide commercialisation via both a kit and a CLIA lab model. Jeanne received her medical degree from University College Dublin. He was previously CEO of 14M Genomics, a cancer molecular diagnostics company, and prior to that served as CEO of Population Genetics Technologies, a business specialising in infectious disease diagnostics and next-generation sequencing technologies. IASLC 2021 World Conference on Lung Cancer | Denver. Earlier roles include those of Global VP Technology Development at GlaxoSmithKline and VP Genetics at Incyte. The Lung Ambition Alliance is a partnership with the International Association for the Study of Lung Cancer (IASLC), the Global Lung Cancer Coalition (GLCC), AstraZeneca and Guardant Health. Inivata is a leader in liquid biopsy. Save the date and visit our virtual booth at the 2020 IASLC World Conference on Lung Cancer taking place as a Worldwide Virtual Event from January 28-31, 2021. Health security and prevention of future COVID-19 outbreaks. She has spent more than 10 years overseeing development and validation of Next Generation Sequencing Assays for both clinical diagnostics and clinical trials and has special interest in applying advanced sequencing technologies (NGS) to improve personalized healthcare. National Immunization Awareness Month; Aug. 1: World Lung Cancer Day; September 2021. IASLC 2021 World Conference on Lung Cancer. Virtual, Interactive Conference. Previously, he was Director of Technology Development at 14M Genomics and Director of Research at Population Genetics Technologies (PGT). To get in touch, use the form below or call [+1] 604 681 2153 / email info@icsevents.com. We are pleased to invite you to the upcoming 18th Annual Winter Lung Cancer Conference ®, a first-class continuing medical 2020 World Conference on Lung Cancer - January 28 - 31, 2021 Alex Spira, MD, PhD, FACP Virginia Cancer Specialists Practice Blog January 28, 2021 For seven months prior to October 2009, he served as Chairman of the Board of Directors, Executive Chairman and Interim Chief Executive Officer. Date: January 26 - 29, 2021. Throughout her career, Charlene has participated in all levels of program teams bringing novel products to global markets, including USA, EU, and China, while working through multiple regulatory pathways, including FDA PMA/510(k), CE Mark and NMPA (formerly CFDA). He started his career in the pharmaceutical industry in 1998 and worked in new product development for Glaxo Wellcome, followed by a series of business development roles in UK biotech. Charlie has also served as a Chief Operations Officer at Emergisoft, a healthcare-based electronic medical records management company where he delivered systems to enterprise clients and successfully launched electronic medical records for maritime. Prior to joining Inivata, Stacy held sales, marketing, market access and general management executive roles leading teams in global and US life science companies including Bristol-Myers Squibb and Sanofi. Tim has a Bachelor of Science in Business Administration from Appalachian State University and is a CPA, having spent the first 15 years of his career with PwC. Overview. He attended Northwestern University to obtain a Master of Science (Medical Informatics). Prior to joining Inivata he formulated and implemented financial controls and process improvements supporting business growth and expansion most recently at Baxano Surgical and Talecris Biotherapeutics. Endorsed Event. These presentations will take place as part of the IASLC 2020 World Conference on Lung Cancer (#WCLC20) hosted by the International Association for the Study of Lung Cancer … He has also been a Collaborating Partner in the President’s National Dialogue on Cancer and acted as Chairman of the Board of Directors to the National Childhood Cancer Foundation in the United States. Craig is a Partner in IP Group’s Life Science investment team. WCLC 2021 Denver - IASLC 22nd World Conference on Lung Cancer - Hotel accommodation. CME Accredited. Filter By. She has served as the sole pharmaceutical industry representative on two Irish government taskforces seeking to enhance the commercialization of IP from Irish academic centres. Before that he worked for Medsolutions, a billion-dollar healthcare-based decision support organization where he headed IT Excellence & Reliability. Biodesix to Showcase New Data on Patient Immune Profiling from Multiple Studies at World Lung Conference. Ten years ago, Robert joined the Cambridge based company Arakis and worked as Medical Director until its £106m sale to Sosei Inc. Over that time, Oxford Immunotec has raised five rounds of venture funding prior to an IPO on NASDAQ in 2013. Robert has a PhD in Genetics from the University of Nottingham and completed postdoctoral fellowships at the University of Rochester, NY and the University of Oxford. She typically works with some of the world's most lethal viruses like Ebola and Marburg. Peter was also the founder and board member of Epemed, a European not for profit organisation bringing together global forces in personalized medicine. The IASLC World Conference on Lung Cancer (IASLC WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. Jeanne’s responsibilities are focused on investing in and managing portfolio investments in the pharmaceuticals and biotechnology areas in Europe. Jacqui Watson is Chief People Officer at Inivata. This is the world’s largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology. From 1982 through 1999, Mr. VanOort served in various positions at Corning, Inc. and at its spin-off company, Quest Diagnostics, Inc. During the period from 1995 through 1999, he served as the Senior Vice President Operations for Quest Diagnostics, Inc. which was then a $1.5 billion newly formed NYSE traded Company. He originally trained in Physics, and specialized in quantitative molecular biology, obtaining a PhD in Systems Biology from the Weizmann Institute of Science, Israel. Lung-MAP translational discoveries shared at 2020 World Conference on Lung Cancer – January 27, 2021 at 01:26PM. Mr. VanOort has served as the Chairman of the Board of Directors and Chief Executive Officer of NeoGenomics since October 28, 2009. Babraham Research Campus, Cambridge, UK, Company Reg: 9144647 Robert has more than 20 years of experience in research and development. January. Location: Singapore. The research was presented today at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer Singapore. Jamie leads the global clinical laboratory operations and has extensive expertise in sequencing and molecular systematics, including population genetics. She is based in London, UK at the Johnson & Johnson Innovation Centre. He is a world-leader in circulating tumor DNA research and since 2009 leads a research group at the Cancer Research UK Cambridge Institute, part of the University of Cambridge. Robert qualified in medicine from University College London, he is a member of the Royal College of Obstetricians & Gynaecologists and the Faculty of Pharmaceutical Medicine and has an MBA from London Business School and an M.Phil in Biostatistics from the University of Cambridge. Privacy Practices 2021 – the ultimate year of the ‘I Am and I Will’ campaign – shows us that our actions have an impact on everyone around us, within our neighbourhoods, communities and cities. Nitzan Rosenfeld is Chief Scientific Officer at Inivata and is also one of Inivata’s founders. CLIA No: 34D2113681 His work combines new molecular and genomics approaches to develop new diagnostic tools and applications. Date Date Date Date CME Accredited CME Accredited. Previously he was head of Computational Biology at Rosetta Genomics, where he led development of molecular diagnostic tests for cancer. IASLC 2019 World Conference on Lung Cancer (WCLC 2019) of the International Association for the Study of Lung Cancer (IASLC) to be held September 7 — 10, 2019 in the vibrant city of Barcelona, Spain. Copyright © 2021 Inivata Ltd|Website Designed & Developed by Identity Creative. Mar 20 - Mar 20 2021. Corning Life Sciences, Inc. had revenues of approximately $2 billion and was spun-off in a public transaction to create both Quest Diagnostics, Inc. and Covance, Inc. From 1982 to 1989, Mr. VanOort served in various executive positions at Corning Inc., including Director of Mergers & Acquisitions. Jamie Platt is Chief Operations Officer at Inivata. She has over 20 years’ experience of leading people and business transformation across different sectors including pharma, IT and hospitality. These are just some of the findings from the annual statistics reported from the American Cancer Society (ACS). His undergrad is in Business Administration. She also holds diplomas in Child Health (NUI) and in Finance and Accounting (ACCA). https://www.inivata.com/events/world-conference-on-lung-cancer-2021 Throughout her career Stacy was recognized with President’s Club, Pinnacle and TWIN awards for outstanding business results, mentorship and patient advocacy. Nitzan is one of Inivata’s founders and its Chief Scientific Officer. Tim also has operational business experience across critical issues including budgeting, investor relations, systems implementation, and risk management. In 2009, Jeanne became VP Alliance Management and Board Director at Janssen Alzheimer Immunotherapy, working with Pfizer and Elan on immunotherapies targeting beta amyloid for Alzheimer’s disease. 2020 World Lung Day. Peter has also served as Chief Business Officer of Yourgene Health, where he led all aspects of commercialization and business development. During the period of 1989 to 1995, he held senior executive positions at Corning Life Sciences, Inc. including Executive Vice President. ... (WCLC), scheduled for January 28-31, 2021… Charlie Kesinger is Chief Information Officer at Inivata. IASLC 21th World Conference on Lung Cancer (WCLC 2020) 2019 European Control Conference; ACM 12th International Workshop on Data and Text Mining in Biomedical Informatics (DTMBio) 2018 ACM 1st International Workshop on Knowledge Management for Healthcare; 12th Workshop on Geographic Information Retrieval In the modern intensive care unit, these bacteria or viruses are usually controlled either by antibiotics or by the body’s immune system within the first few days of the illness. Why attend TTLC 2021? Licenses and Accreditation. He also holds an MBA with Distinction from the University of Warwick where he was awarded a Sainsbury Management Fellowship from the Royal Academy of Engineering. Location Location She spent 11 years in Licensing and Acquisition, most recently as Global Head of Scientific Licensing for Johnson & Johnson’s Pharmaceutical business, having joined the Johnson & Johnson Family of Companies in 2005 from the Business Development group at GSK. Peter holds a BSc in Biological Sciences from Plymouth University. He originally trained in Physics, and specialized in quantitative molecular biology, obtaining a PhD in Systems Biology from the Weizmann Institute of Science, Israel. ... January 31, 2021 Peter brings over 30 years of experience working in the biopharmaceutical sector, having held senior leadership positions in several molecular diagnostics companies, most recently at Guardant Health. Joining the team as a consultant in early 2018, Stacy quickly leveraged her healthcare sales, marketing, market access and operations experience to build and accelerate the commercialization strategy for InVisionFirst®-Lung. She was appointed as a Peer Ambassador at Emory Winship Cancer Center in 2018. July 2021. All Times will be in Eastern Time. Prior to this, Peter was Vice President, Head of Diagnostics at GSK – where he was responsible for the companion diagnostics assets and pipeline across all therapeutic areas, particularly oncology – and VP, Pharma Business Development at QIAGEN. After seven years working in hospital medicine, Robert joined the pharma industry in 1996 working in development and regulatory roles at Sanofi, the MHRA and Roche where he led the clinical team for the regulatory approval of Valcyte®. Clive worked for over a decade in various key roles at AstraZeneca, where he oversaw R&D and medical affairs projects and groups on a global scale, was involved in R&D strategy, investor relations, and led the major transformation of AstraZeneca’s UK strategic R&D sites and global HQ. During her 15 years in clinical diagnostics, Jamie has developed and validated numerous high complexity sequencing assays in the clinical areas of Oncology, Infectious Disease and Molecular Genetics and has introduced custom, industrial-grade automation to high complexity, sequencing assays. Peter Collins is Chief Business Officer at Inivata. All rights reserved. Alan holds a PhD from the University of Southern California and has authored numerous publications in the molecular genetics field. Robert joined Cambridge Innovation Capital as Investment Director in January 2014. InVisionSeq and eTAm-Seq are UK registered trade marks of Inivata Limited. The theme: 2019 - 2021 2021: Together, all our actions matter. Build connections with colleagues from around the world including prominent researchers and physicians. Nitzan has authored dozens of patents and research articles on methods for molecular diagnostics and cell-free DNA analysis. Takeda to Hold Investor Call on January 29 During World Conference on Lung Cancer. David Harpole, IASLC WCLC 2021. Robert has authored 16 patents, including key early work on molecular barcoding technologies. Thank you for contacting us, one of our division managers will respond to you shortly. He has extensive experience across all phases of drug development including seven marketed or close-to-market oncology products. Clive worked for over a decade in various key roles at AstraZeneca, where he oversaw R&D and medical affairs projects and groups on a global scale, was involved in R&D strategy, investor relations, and led the major transformation of AstraZeneca’s UK strategic R&D sites and global HQ. Clive Morris is Chief Executive Officer at Inivata. The International Association for the Study of Lung Cancer (IASLC) presented potentially practice-changing studies and recent advances in thoracic oncology at the IASLC WCLC 2020 … This includes a 2.4% decline from 2017 to 2018—a new record for the largest 1-year drop in the cancer death rate. Prior to joining NeoGenomics, Mr. VanOort was a General Partner with a Private Equity Firm, and a Founding Managing Partner of a Venture Capital Firm. Home. Tim manages finance, administration and legal activities. This World Cancer Day, who are you and what will you do? Most recently Clive founded and lead Health Innovation Manchester, to develop an innovation ecosystem involving the decentralisation of £6bn per annum of health and social care services. She is a Fellow of the Royal Academy of Medicine of Ireland (RAMI). Stacy is an Emeritus Member of the Terry College of Business Alumni Board at the University of Georgia, Board Member of Our Brain Bank, and holds membership in the International Association for the Study of Lung Cancer (IASLC), Women’s Business Leadership, Healthcare Businesswomen’s Association, and the Leukemia & Lymphoma Society. Back to School with Asthma; Tips for Traveling with COPD and Asthma; August 2021. For his contributions, he was awarded the CRUK Future Leaders in Cancer Research prize, the British Association for Cancer Research Translational Research Award, and the Academy of Medical Sciences Foulkes Medal. IASLC postpones World Conference on Lung Cancer to January 26 to 29, 2021 in Singapore International Association for the Study of Lung Cancer Real World Experience from the Front Lines: COVID-19, Acute Lung Injury and ARDS Virtual Panel Discussion Interim Outcomes Report (as of January 2021) Boehringer Ingelheim Grant ID: IME -2020-00002460. Activity Description: As the first initiative in a series of six educational programs, this panel discussion featured a Dr Wrighton-Smith has a Masters in Engineering, Economics and Management, and a Doctorate in Medical Engineering, both from University of Oxford. Sept. 16: Get Ready Day; Sept. 29: World Heart Day; October 2021. Open the Site. Open the Site. 2021. Clive is accredited as a Pharmaceutical Medicine specialist by the UK Royal College of Physicians, has an Executive MBA and trained as a physician at the University of Manchester. January 11, 2021 | By Marla Paul Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung within hours. Charlie has a PhD in Organizational Leadership. Along her career path Charlene has held positions and executive roles at both start-ups and large corporations, including Kiyatec, Becton Dickinson, Micell Technologies, LabCorp, EndoTex, Somnus, and Avocet, covering a vast array of technologies focused in oncology, cardiovascular medical devices/combination products and the personalized medicine diagnostic space. Join us at the IASLC 2021 Targeted Therapies of Lung Cancer Meeting. Throughout her career Jacqui has focussed on inspiring individuals and teams to reach their full potential and in her current role she is responsible for the alignment of our organisational human resource processes to help drive our business success. IASLC 2021 World Conference on Lung Cancer | Denver. TAm-Seq and InVisionFirst are UK and EU registered trade mark of Inivata Limited Terms & Conditions Nitzan authored dozens of patents and research articles on methods for molecular diagnostics and cell-free DNA analysis. INIVATA and InVision are UK, EU and US registered trade marks of Inivata Limited It is our great pleasure and honor to extend a warm invitation to attend and participate in the IASLC 2021 World Conference on Lung Cancer (#WCLC21) of the International Association for the Study of Lung Cancer (IASLC) to be held September 11 - 14, 2021 in Denver (WCLC 2021 Denver). Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients.